RecruitingNot Applicable

FX Shoulder Prospective Clinical Study

United States600 participantsStarted 2021-03-31

Plain-language summary

Prospective Multi-Center Registry on study subjects with implanted devices marketed and legally commercialized in the USA by FX Shoulder Solutions.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Receive an FX shoulder replacement medical device in accordance with the Indications for Use for the selected device system. Exclusion Criteria: Patient who does not meet the inclusion criteria.

What they're measuring

A patient is considered a success at post-operative follow-up based upon the following composite clinical success (CCS):

Timeframe: 2 years

Survivorship

Timeframe: 10 years

Trial details

NCT IDNCT06078865

SponsorFX Shoulder Solutions

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2031-12-30

Contact for this trial

Brian Wasonga, MHA

800-280-0775 bwasonga@fxshouldersolutions.com

View on ClinicalTrials.gov More Osteoarthritis Shoulder trials